Non-invasive prenatal testing (NIPT) uses a blood test to screen for chromosome abnormalities like Down syndrome early in pregnancy. Some women use positive results to terminate pregnancies or prepare for a child with disabilities, while critics argue it degrades the value of disabled children. Most women (over 90%) terminate if prenatal testing shows Down syndrome. As genetic testing becomes more widespread and affordable, it raises debates around abortion, disability rights, and eugenics.